Houston, TX, United States of America

Warefta Hasan

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2020-2021

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Warefta Hasan in Immunostimulatory Agents

Introduction

Warefta Hasan is an accomplished inventor based in Houston, Texas. He has made significant contributions to the field of immunology through his innovative work on spherical nucleic acid-based constructs. With a total of two patents to his name, Hasan is recognized for his advancements in therapeutic applications.

Latest Patents

Warefta Hasan's latest patents focus on the development of spherical nucleic acid-based constructs as immunostimulatory agents. These inventions relate to methods and compositions that activate agonists of nucleic acid interacting complexes, such as Toll-like receptors (TLRs). The compositions are designed to stimulate an immune response and have potential applications in treating various diseases, including infectious diseases, cancer, allergies, and autoimmune disorders.

Career Highlights

Hasan's career is marked by his dedication to research and innovation in the field of immunology. His work has led to advancements that could significantly impact therapeutic strategies for a range of diseases. He is currently associated with Exicure, Inc., where he continues to develop groundbreaking technologies.

Collaborations

Warefta Hasan collaborates with notable colleagues, including Aleksandar Filip Radovic-Moreno and Christopher C. Mader. These partnerships enhance the research and development efforts within his field.

Conclusion

In summary, Warefta Hasan is a prominent inventor whose work on spherical nucleic acid-based constructs has the potential to revolutionize immunotherapy. His contributions to the field are invaluable, and his ongoing research promises to yield further advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…